IBDEI14Z ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18981,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18981,1,3,0)
 ;;=3^Transcobalamin II Deficiency
 ;;^UTILITY(U,$J,358.3,18981,1,4,0)
 ;;=4^D51.2
 ;;^UTILITY(U,$J,358.3,18981,2)
 ;;=^5002286
 ;;^UTILITY(U,$J,358.3,18982,0)
 ;;=D05.92^^94^916^33
 ;;^UTILITY(U,$J,358.3,18982,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18982,1,3,0)
 ;;=3^Carcinoma in Situ Left Breast,Unspec Type
 ;;^UTILITY(U,$J,358.3,18982,1,4,0)
 ;;=4^D05.92
 ;;^UTILITY(U,$J,358.3,18982,2)
 ;;=^5001937
 ;;^UTILITY(U,$J,358.3,18983,0)
 ;;=D05.91^^94^916^35
 ;;^UTILITY(U,$J,358.3,18983,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18983,1,3,0)
 ;;=3^Carcinoma in Situ Right Breast,Unspec Type
 ;;^UTILITY(U,$J,358.3,18983,1,4,0)
 ;;=4^D05.91
 ;;^UTILITY(U,$J,358.3,18983,2)
 ;;=^5001936
 ;;^UTILITY(U,$J,358.3,18984,0)
 ;;=D05.90^^94^916^31
 ;;^UTILITY(U,$J,358.3,18984,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18984,1,3,0)
 ;;=3^Carcinoma in Situ Breast Unspec,Unspec Type
 ;;^UTILITY(U,$J,358.3,18984,1,4,0)
 ;;=4^D05.90
 ;;^UTILITY(U,$J,358.3,18984,2)
 ;;=^5001935
 ;;^UTILITY(U,$J,358.3,18985,0)
 ;;=D51.0^^94^916^185
 ;;^UTILITY(U,$J,358.3,18985,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18985,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia d/t Intrinsic Factor Deficiency
 ;;^UTILITY(U,$J,358.3,18985,1,4,0)
 ;;=4^D51.0
 ;;^UTILITY(U,$J,358.3,18985,2)
 ;;=^5002284
 ;;^UTILITY(U,$J,358.3,18986,0)
 ;;=D51.1^^94^916^186
 ;;^UTILITY(U,$J,358.3,18986,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18986,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia d/t Selective Vit B12 Malabsorp w/ Proteinuria
 ;;^UTILITY(U,$J,358.3,18986,1,4,0)
 ;;=4^D51.1
 ;;^UTILITY(U,$J,358.3,18986,2)
 ;;=^5002285
 ;;^UTILITY(U,$J,358.3,18987,0)
 ;;=D51.9^^94^916^188
 ;;^UTILITY(U,$J,358.3,18987,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18987,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,18987,1,4,0)
 ;;=4^D51.9
 ;;^UTILITY(U,$J,358.3,18987,2)
 ;;=^5002289
 ;;^UTILITY(U,$J,358.3,18988,0)
 ;;=D68.0^^94^916^190
 ;;^UTILITY(U,$J,358.3,18988,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18988,1,3,0)
 ;;=3^Von Willebrand's Disease
 ;;^UTILITY(U,$J,358.3,18988,1,4,0)
 ;;=4^D68.0
 ;;^UTILITY(U,$J,358.3,18988,2)
 ;;=^127267
 ;;^UTILITY(U,$J,358.3,18989,0)
 ;;=C88.0^^94^916^191
 ;;^UTILITY(U,$J,358.3,18989,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18989,1,3,0)
 ;;=3^Waldenstrom Macroglobulinemia
 ;;^UTILITY(U,$J,358.3,18989,1,4,0)
 ;;=4^C88.0
 ;;^UTILITY(U,$J,358.3,18989,2)
 ;;=^5001748
 ;;^UTILITY(U,$J,358.3,18990,0)
 ;;=C91.02^^94^916^3
 ;;^UTILITY(U,$J,358.3,18990,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18990,1,3,0)
 ;;=3^Acute Lymphoblastic Leukemia,In Relapse
 ;;^UTILITY(U,$J,358.3,18990,1,4,0)
 ;;=4^C91.02
 ;;^UTILITY(U,$J,358.3,18990,2)
 ;;=^5001764
 ;;^UTILITY(U,$J,358.3,18991,0)
 ;;=C92.02^^94^916^6
 ;;^UTILITY(U,$J,358.3,18991,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18991,1,3,0)
 ;;=3^Acute Myeloblastic Leukemia,In Relapse
 ;;^UTILITY(U,$J,358.3,18991,1,4,0)
 ;;=4^C92.02
 ;;^UTILITY(U,$J,358.3,18991,2)
 ;;=^5001791
 ;;^UTILITY(U,$J,358.3,18992,0)
 ;;=D09.3^^94^916^43
 ;;^UTILITY(U,$J,358.3,18992,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18992,1,3,0)
 ;;=3^Carcinoma in Situ of Thyroid/Oth Endocrine Glands
 ;;^UTILITY(U,$J,358.3,18992,1,4,0)
 ;;=4^D09.3
 ;;^UTILITY(U,$J,358.3,18992,2)
 ;;=^5001955
 ;;^UTILITY(U,$J,358.3,18993,0)
 ;;=C22.0^^94^916^84
 ;;^UTILITY(U,$J,358.3,18993,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18993,1,3,0)
 ;;=3^Hepatocellular Carcinoma
 ;;^UTILITY(U,$J,358.3,18993,1,4,0)
 ;;=4^C22.0
